Cargando…
Dual-Acting Peripherally Restricted Delta/Kappa Opioid (CAV1001) Produces Antinociception in Animal Models of Sub-Acute and Chronic Pain
BACKGROUND: The development of highly efficacious alternatives to mu-opioid analgesics represents an urgent unmet medical and public health need. In the presence of inflammation both delta- and kappa-opioid agonists, acting on peripheral sensory neurons, mediate analgesia. The dual-acting, periphera...
Autores principales: | Hartrick, Craig T, Poulin, Dominic, Molenaar, Rebekka, Hartrick, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547792/ https://www.ncbi.nlm.nih.gov/pubmed/33116788 http://dx.doi.org/10.2147/JPR.S262303 |
Ejemplares similares
-
Exploiting Injury-Induced Peripheral Opioid Receptor Changes in Novel Analgesic Development for Chronic Pain
por: Hartrick, Craig T.
Publicado: (2022) -
Characterization of the Antinociceptive Activity from Stevia serrata Cav
por: Cordeiro, Millena S., et al.
Publicado: (2020) -
Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
por: Wang, Xin, et al.
Publicado: (2021) -
Effect of preoperative oral antibiotics in combination with mechanical bowel preparation on inflammatory response and short‐term outcomes following left‐sided colonic and rectal resections
por: Hartrick, O., et al.
Publicado: (2020) -
Editorial: Pain 360: Emerging topics in the pathophysiology, diagnosis, and treatment of chronic pain
por: Hartrick, Craig T., et al.
Publicado: (2023)